"Let food be your medicine, and let medicine be your food" Hippocrates (^^ - 500BC)
|
Nutri Pharma ASAKronprinsesse Marthas
Plass 1 P.O Box 1477, Vika N-0116 Oslo Norway Telephone +47 23 01 09 60 Telefax +47 23 01 09 70 Send e-mail |
Press RoomNutri Pharmas’s information policy aims at a regular contact with the various stakeholders of the company. Emphasis is placed
on keeping markets continuously informed about events to enable the investment community to value the company. Nutri Pharma
intends to achieve this by presenting results, publishing quarterly and annual reports, communication towards analysts and
financial media in addition to public disclosure of significant events.
Thorleif Krarup proposed as new Chairman of Nutri Pharma ASA25.01.2010 - Thorleif Krarup to be proposed as new Chairman of the Board in Extraordinary Shareholders Meeting to be held
on February 12...
Private Placement23.01.2010 - Nutri Pharma ASA refers to stock exchange release dated 21 January regarding contemplated private placement as
a condition for the completion of the offer to
shareholders in Bionor...
Extraordinary shareholders meeting22.01.2010 - Notice for extraordinary shareholders meeting Nutri Pharma has today sent the attached notice to shareholders
of the company....
Status Offer for shares in Bionor Immuno; contemplated private placement21.01.2010 - With reference to the release 20 January and the release 12 January and theoffer document for offer to shareholders
in Bionor Immuno AS (the "Offer"), Nutri Pharma ASA ("Nutri Pharma" or the "Company")...
Offer for shares in Bionor Immuno AS20.01.2010 - With reference to the release 12 January and the offer document for offer to shareholders in Bionor Immuno, Nutri
Pharma announces that it has received
acceptances for 96,54% of the shares in Bionor Immuno...
Mandatory notification of trade18.01.2010 - Board member Lars H. Høie has today purchased 2.000.000 NUT shares at NOK 2.81 per share....
Voluntary offer from Nutri Pharma ASA to purchase shares in Bionor Immuno AS14.01.2010 - Nutri Pharma ASA ("Nutri Pharma") hereby presents the voluntary offer to purchase shares in Bionor Immuno AS
("Bionor")....
Nutri Pharma ASA to launch a voluntary offer for vaccine developer Bionor Immuno AS12.01.2010 - Nutri Pharma ASA ("Nutri Pharma") to submit a voluntary exchange offer ("Offer") for all outstanding shares in
Bionor Immuno AS("Bionor"). The shareholders of Bionor will be offered 1 Nutri Pharma share per 2 shares in Bionor...
PRESS CONTACT For further information on Nutri Pharma, please contact CEO Trond Syvertsen on telephone +47 2331 0880 or send us an
e-mail
|
2006 Nutri Pharma ASA Telephone +47 23 01 09 60 Telefax +47 23 01 09 70
Contact Page
